Description
Using our intelligently designed and intuitive dataset, you can quickly understand how Walgreens Co. (WBA) is lobbying the U.S. government, how much they’re spending on it, and most importantly – the bills and specific issues on which they lobby.
Gain an informational edge with our Lobbying Data Intelligence. Perform analysis by company, lobbyist, lobbying firm, government agency, or issue.
For lobbying firms: understand your competitors. Understand who is registering with who. Gain insight on quarterly reports and specific issues other firms are lobbying on.
Our lobbying data is collected and aggregated from the U.S. Senate Office of Public Records from 1999-present and is updated on a regular basis. We utilize advanced data science techniques to ensure accurate data points are collected and ingested, match similar entities across time, and tickerize publicly traded companies that lobby.
Our comprehensive and advanced lobbying database is completed with all the information you need, with more than 1.6 million lobbying contracts ready-for-analysis. We include detailed information on all aspects of federal lobbying, including the following fascinating attributes, among much more:
1. Clients: The publicly traded company, privately owned company, interest group, NGO, or state or local government that employs or retains a lobbyist or lobbying firm.
2. Registrants (Lobbying Firms): Either the name of the lobbying firm hired by the client, or the name of the client if the client employs in-house lobbyists.
3. Lobbyists: The names and past government work experience of the individual lobbyists working on a lobbying contract. 3. General Issues: The general issues for which clients lobby on (ex: ENV – Environment, TOB – Tobacco, FAM – Family Issues/Abortion).
4. Specific Issues: A long text description of the exact bills and specific issues for which clients lobby on.
5. Bills Lobbied On: The exact congressional bills and public/private laws lobbied on, parsed from lobbying report specific issues (ex: H.R. 2347, S. 1117, Tax Cuts and Jobs Act).
6. Agencies Lobbied: The names of one or more of 250+ government agencies lobbied on in the contract (ex: White House, FDA, DOD).
7. Foreign Entities: The names and origin countries of entities affiliated with the client (ex: BNP Paribas: France).
Gain access to our highly unique and actionable U.S. lobbying database. Further information on LobbyingData.com and our alternative datasets and database can be found on our website, or by contacting [email protected].
Frequently Asked Questions
What is Walgreens Co. (WBA) lobbying for?
Summary of Walgreens Co.’s Lobbying Data:
– Lobbying Firms: Forbes-Tate, Guidepoststrategies, Llc
– General Issues: Taxation/Internal Revenue Code, Computer Industry, Pharmacy, Health Issues, Veterans, Medicare/Medicaid, Copyright/Patent/Trademark, Budget/Appropriations
– Specific Issues: Covid funding, Medicare reimbursement, Section 965 – Treatment of Deferred Foreign Income, global intangible low taxed income (GILTI), 163(n) language, INFORM Consumers Act, opioids, implementation of the CARES Act, H.R. 5376 – Inflation Reduction Act of 2022, H.R.7213 – Equitable Community Access to Pharmacist Services Act, H.R.4521 America COMPETES Act, direct and indirect remuneration (DIR) issues, provider status issues, healthcare service issues
– Government Agencies: Senate, Executive Office of the President (EOP), House of Representatives
One could infer that Walgreens Co. is lobbying on a variety of healthcare-related issues because it is a major national pharmacy chain that derives a significant portion of its revenue from the healthcare industry. They likely lobby on issues related to taxation and budget/appropriations in order to protect their bottom line and maintain profitability. Additionally, they may be lobbying on issues related to coronavirus funding and treatment in order to ensure that they are able to provide essential services and supplies to their customers amidst a public health crisis. The patent/trademark issues are likely related to legal issues involving prescription drugs or medical devices that the company sells. Overall, the lobbying efforts seem to be geared towards protecting Walgreens Co.’s interests and staying competitive in the healthcare industry.
